Abstract
Background: The inherited bone marrow failure syndrome dyskeratosis congenita (DC) is most frequently caused by mutations in DKC1 (MIM# 300126), the gene encoding NAP57 (aka dyskerin). The typically missense mutations modulate the interaction of NAP57 with its chaperone SHQ1, but no DC mutations have been identified in SHQ1 (MIM# 613663). Here, we report on two compound heterozygous mutations in SHQ1 in a patient with a severe neurological disorder including cerebellar degeneration. Methods: The SHQ1 mutations were identified by patient exome sequencing. The impact of the mutations was assessed in pulldown assays with recombinant NAP57. Results: The SHQ1 mutations were the only set of mutations consistent with an autosomal recessive mode of inheritance. The mutations map to the SHQ1-NAP57 interface and impair the interaction of the recombinant SHQ1 variants with NAP57. Conclusion: Intrauterine growth retardation and the neurological phenotype of the patient are reminiscent of the severe clinical variant of DC, the Hoyeraal-Hreidarsson syndrome (HH). Hence, SHQ1 screening may be warranted in patients with inherited bone marrow failure syndromes.
Original language | English (US) |
---|---|
Pages (from-to) | 805-808 |
Number of pages | 4 |
Journal | Molecular Genetics and Genomic Medicine |
Volume | 5 |
Issue number | 6 |
DOIs | |
State | Published - Nov 2017 |
Keywords
- H/ACA RNP
- Hoyeraal-Hreidarsson syndrome
- compound heterozygous mutations
- dyskeratosis congenita
- protein-protein interaction
- ribonucleoprotein (RNP) biogenesis
ASJC Scopus subject areas
- Molecular Biology
- Genetics
- Genetics(clinical)